Use App
Trending
News
Earnings
Newsletters
Work With Us
All
DIA
0.58%
SPY
0.30%
QQQ
0.35%
Trending
BMNR
3.67%
HOOD
4.89%
SPHL
651.84%
PATH
2.96%
MLEC
103.84%
THH
90.20%
AMD
2.90%
CRCL
6.77%
JBHT
6.94%
SPOT
4.53%
BMNR
3.67%
HOOD
4.89%
SPHL
651.84%
PATH
2.96%
MLEC
103.84%
THH
90.20%
AMD
2.90%
CRCL
6.77%
JBHT
6.94%
SPOT
4.53%
home
Symbol
CNSP
CNSP
Cns Pharmaceuticals Inc
7,949
Mkt Cap
$3.85M
Volume
1.03M
52W High
$114.00
52W Low
$4.93
PE Ratio
-0.11
CNSP Fundamentals
Price
$7.37
Prev Close
$6.20
Open
$6.43
50D MA
$6.51
Beta
0.98
Avg. Volume
19,901.95
EPS (Annual)
-$466.44
P/B
0.36
Rev/Employee
$0.00
PE Ratio
-0.11
Loading...
Loading...
Feed
News
Sentiment
Fundamentals
Info
News
all
press releases
CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved
The company intends to commence the phase 2 study of its lead program, TPI 287, to treat Glioblastoma Multiforme (GBM) by year-end.
Stocktwits
·
8mo ago
Full Article
<
...
1
>
Latest CNSP News
View
Top Discussions
top
active
trending
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile